Fact checked byKristen Dowd

Read more

June 24, 2024
2 min read
Save

Risk for lung cancer reoccurrence may be associated with OSA-related hypoxemia

Fact checked byKristen Dowd
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • In univariate analysis, a 4% oxygen desaturation index greater than 15 was significantly linked to lung cancer reoccurrence.
  • Two hypoxic burden measures continued to be significant in adjusted analysis.

Potential risk factors for lung cancer reoccurrence within 2 years include obstructive sleep apnea-related episodic hypoxemia and hypoxic burden, according to research presented at SLEEP 2024.

“We were suspecting that we would find a positive association between measures of intermittent hypoxemia and lung cancer reoccurrence; nonetheless, we never expected to see such a strong signal,” Fernando Figueroa Rodriguez, MD, sleep medicine fellow at the Mayo Clinic in the division of pulmonary, critical care and sleep medicine in Rochester, Minnesota, said in a press release.

3D rendered illustration of lung cancer.
Potential risk factors for lung cancer reoccurrence within 2 years include obstructive sleep apnea-related episodic hypoxemia and hypoxic burden, according to presented research. Image: Adobe Stock

In a retrospective record review, Figueroa Rodriguez and colleagues evaluated 403 adults (median age, 74 years; 52% women) with history of non-small cell lung cancer (NSCLC) and overnight oximetry study data 3 years before receiving curative malignancy treatment to determine the link between OSA-related episodic hypoxemia and lung cancer reoccurrence in less than 2 years.

Within the cohort, 68% had a histological subtype of adenocarcinoma, whereas 22% had a subtype of squamous cell carcinoma.

Researchers identified patients’ NSCLC stage using the tumor, node and metastasis (TNM) system and found 35% with stage IA1, 24.1% with stage IA2 and 19% with stage IB cancer.

Most of the study population did not experience lung cancer again, but 22% (n = 68) did experience reoccurrence.

Regardless of included demographics, histologic subtype and cancer stage, univariate analysis revealed significant relationships (P < .001) between lung cancer reoccurrence in less than 2 years and OSA-related episodic hypoxemia, as well as hypoxic burden measures:

  • 4% oxygen desaturation index (ODI) greater than 15;
  • time spent in desaturation;
  • time spent below 89% SpO2;
  • average SpO2 below 89%; and
  • single nadir oxygen levels.

Researchers noted that only two of the above factors were still “strongly correlated” with lung cancer recurrence in less than 2 years when using a multivariate proportional hazard survival model: average SpO2 below 89% and single nadir oxygen level.

“The multivariate model demonstrated correlation with hypoxic load measures only, suggesting the need for a larger sample to elucidate the involvement of this highly treatable risk factor,” Figueroa Rodriguez and colleagues wrote.

Reference: